COSCIENS Biopharma Inc T.CSCI

Alternate Symbol(s): CSCI

Healthcare Biotechnology

COSCIENS Biopharma Inc., formerly Aeterna Zentaris Inc., is a specialty biopharmaceutical company engaged in the development and commercialization of a diverse portfolio of pharmaceutical and diagnostic products, including those focused on areas of unmet medical need. Its lead product, macimorelin (Macrilen; Ghryvelin), is an oral test indicated for the diagnosis of adult growth hormone deficiency (AGHD). The Company is also engaged in the development of therapeutic assets and proprietary extraction technology, which is applied to the production of active ingredients from renewable plant resources used in cosmeceutical products (i.e., oat beta glucan and avenanthramides, which are found in skincare product brands like Aveeno and Burt’s Bees formulations) and being developed as potential nutraceuticals and/or pharmaceuticals.

TSX:CSCI - Post by User

COSCIENS Biopharma Inc

<< Previous

Bullboard Posts

Next >>

Post by prophetoffactzon Aug 22, 2024 12:09pm

65 Views

Post# 36191953

Wound healing: Dr. Vincent Li:

@ 26:30

"I think it is very translatable..." into humans.

"Most of the therpeutics out there actually go through the same path."

"The mechanisms of healing in rodents and humans are similar other than the fact that rodents have an extra piece of muscle that we've been kind of able to control... We are very optimistic that we are going to find some very, very similar results when we go into humans."

---

He talked about it being like Intel Inside, in a sense, and using the science in bandages, gauze, etc.

Virtual Investor: Summer Spotlight Series Featuring Ceapro Inc. (TSX-V: CZO; OTCQX: CRPOF) - Zoom

<< Previous

Bullboard Posts

Next >>

The top 5 mining dividend stocks in Canada